{"id":"NCT00218426","sponsor":"University of Pennsylvania","briefTitle":"Addiction Treatment in Russia: Oral vs. Naltrexone Implant","officialTitle":"Addiction Treatment in Russia: Oral and Depot Naltrexone","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2006-07","primaryCompletion":"2009-06","completion":"2010-11-04","firstPosted":"2005-09-22","resultsPosted":"2019-02-27","lastUpdate":"2019-03-18"},"enrollment":306,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heroin Dependence","Opioid-Related Disorders"],"interventions":[{"type":"DRUG","name":"naltrexone implant","otherNames":["DNI"]},{"type":"DRUG","name":"oral naltrexone","otherNames":["ON"]},{"type":"DRUG","name":"oral placebo naltrexone","otherNames":["ONP"]},{"type":"DRUG","name":"placebo implant","otherNames":["DNIP"]}],"arms":[{"label":"ONP + DNI","type":"ACTIVE_COMPARATOR"},{"label":"ON + DNIP","type":"ACTIVE_COMPARATOR"},{"label":"ONP + DNIP","type":"PLACEBO_COMPARATOR"}],"summary":"Heroin addiction is a growing problem in Russia; individuals who enter heroin addiction treatment often relapse. Therefore, effective heroin addiction treatments are necessary to prevent relapse. The purpose of this study is to compare oral naltrexone with a naltrexone implant that provides opioid blockade for two months in preventing relapse to heroin addiction in St. Petersburg, Russia.","primaryOutcome":{"measure":"Retention Without Relapse to Heroin Addiction (Measured at Month 6)","timeFrame":"6 months","effectByArm":[{"arm":"ON + DNIP, Oral Naltrexone + Depot Placebo Naltrexone Implant","deltaMin":54,"sd":null},{"arm":"DNI + ONP , Naltrexone Implant + Oral Naltrexone Placebo","deltaMin":16,"sd":null},{"arm":"ONP + DNIP, Oral Placebo Naltrexone and Depot Placebo Implant","deltaMin":11,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":2,"countries":["United States","Russia"]},"refs":{"pmids":["40342086","27436632"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":102},"commonTop":["local site reaction","nausea","drowsiness","increased liver enzyme","bronchitis"]}}